Log in to download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Holder | DMF No. | Subject | Submission Date | Status | Type | GDUFA DMF Review | GDUFA Review Date | GDUFA Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 31/10/2025 | The Division of Cancer Treatment and Diagnosis |
U.S.A |
NATIONAL CANCER INSTITUTE | 4417 | SANGIVAMYCIN HCL (NSC 143648) AS PREPARED BY THE FREDERICK CANCER RES. | 1982-01-27 | Inactive | II | N/A |
